U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653685) titled 'A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer' on June 12.
Brief Summary: To assess the safety and preliminary efficacy of TQB2930 and chemotherapy with or without bevacizumab in subjects with HER2-positive unresectable locally advanced or metastatic colorectal cancer (CRC).
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: TQB2930 injection + Oxaliplatin injection + Capecitabine tablets + Bevacizumab injection
TQB2930 enhances the binding to HER2 protein on the surface of tumor cells and ...